Diagnos Laboratorium Utama PT Tbk (DGNS) — Financial Flexibility Index
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Financial Flexibility Index of 0.04x as of June 2025. Free cash flow of Rp4.16 Billion (operating CF Rp1.52 Billion minus capex Rp2.64 Billion) represents 0% of total liabilities (Rp110.07 Billion). Check Diagnos Laboratorium Utama PT Tbk (DGNS) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diagnos Laboratorium Utama PT Tbk Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Diagnos Laboratorium Utama PT Tbk across 8 annual periods. See Diagnos Laboratorium Utama PT Tbk short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year free cash flow to debt coverage for Diagnos Laboratorium Utama PT Tbk. For the full company profile including market capitalisation, see market value of Diagnos Laboratorium Utama PT Tbk.
| Year | Flexibility Index | Free Cash Flow (IDR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.68x | Rp70.69 Billion | Rp27.30 Billion | Rp103.89 Billion | ▲ +0.2% |
| 2023 | 0.68x | Rp51.51 Billion | Rp13.18 Billion | Rp75.88 Billion | ▼ -30.5% |
| 2022 | 0.98x | Rp28.84 Billion | Rp-6.02 Billion | Rp29.51 Billion | ▼ -69.0% |
| 2021 | 3.15x | Rp126.72 Billion | Rp58.87 Billion | Rp40.18 Billion | ▲ +229.3% |
| 2020 | 0.96x | Rp32.09 Billion | Rp26.23 Billion | Rp33.51 Billion | ▼ -12.6% |
| 2019 | 1.10x | Rp13.98 Billion | Rp11.20 Billion | Rp12.76 Billion | ▼ -0.5% |
| 2018 | 1.10x | Rp12.30 Billion | Rp8.47 Billion | Rp11.17 Billion | ▲ +1609.3% |
| 2017 | -0.07x | Rp-384.52 Million | Rp-712.00 Million | Rp5.27 Billion | — |